Inovio | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$22,500,000
Funder
Coalition for Epidemic Preparedness Innovations (CEPI)
Principal Investigator
Kate Broderick
Research Location
United States of America
Lead Research Institution
Inovio
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Phase 1 clinical trial
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

DNA plasmid with electroporation, coding for full-length spike protein of SARS-CoV-2 Phase I/II

Publicationslinked via Europe PMC

Last Updated:14 hours ago

View all publications at Europe PMC

Candidate transmission survival genome of <i>Mycobacterium tuberculosis</i>.

Upconversion Nanoparticle-Covalent Organic Framework Core-shell Particles as Therapeutic Microrobots Trackable With Optoacoustic Imaging.

What are the experiences and support needs of district nurses caring for terminally ill people with delirium at home? A qualitative study.

Structure of activity in multiregion recurrent neural networks.

Use of diagnostic vs low-dose computed tomography in positron emission tomography-CT examinations.

The mechanism of electrical conduction in glassy semiconductors.

Treatments of fatigue after spinal cord injury: a systematic review and meta-analysis.

Energy filtering enables macromolecular MicroED data at sub-atomic resolution.

Application of restorative neurostimulation for chronic mechanical low back pain in an older population with 2-year follow up.